(Q36795404)

English

Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer

scientific article published on July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer (English)

1 reference

Europe PubMed Central

16 August 2017

author name string

Sertznig P

1

1 reference

Europe PubMed Central

16 August 2017

Seifert M

2

1 reference

Europe PubMed Central

16 August 2017

Tilgen W

3

1 reference

Europe PubMed Central

16 August 2017

Reichrath J

4

1 reference

Europe PubMed Central

16 August 2017

publication date

1 July 2007

1 reference

Europe PubMed Central

16 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Cellular Physiology

1 reference

Europe PubMed Central

16 August 2017

212

1 reference

Europe PubMed Central

16 August 2017

1-12

1 reference

Europe PubMed Central

16 August 2017

1

1 reference

Europe PubMed Central

16 August 2017

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Oxidants, antioxidants, and the degenerative diseases of aging

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2).

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Nuclear receptors and lipid physiology: opening the X-files

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of two mPPAR related receptors and evidence for the existence of five subfamily members

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A phase II trial with rosiglitazone in liposarcoma patients

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Inhibition of melanoma metastases by fenofibrate

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARs: transcriptional effectors of fatty acids and their derivatives

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Measures of cell replication in risk/safety assessment of xenobiotic-induced, nongenotoxic carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression and function of peroxisome proliferator-activated receptors in human melanocytes

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors: from genes to physiology

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors in cutaneous biology

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of PPARdelta alters lipid metabolism in db/db mice.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Biochemical mechanisms of induction of hepatic peroxisome proliferation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The RXR heterodimers and orphan receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Cloning and function of rabbit peroxisome proliferator-activated receptor delta/beta in mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome-proliferator-activated receptors and cancers: complex stories

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Terminal differentiation of human breast cancer through PPAR gamma.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Effects of N-3 fatty acids on lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

15-Deoxy-Δ-12-14-PGJ2 Regulates Apoptosis Induction and Nuclear Factor-κB Activation Via a Peroxisome Proliferator-Activated Receptor-γ–Independent Mechanism in Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Novel sequence determinants in peroxisome proliferator signaling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Modulation of fatty acid signalling by cytochrome P-450-mediated hydroxylation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Therapeutic potential of thiazolidinediones as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma as a therapeutic target for tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR gamma signaling exacerbates mammary gland tumor development

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Obesity and the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Alteration of a Single Amino Acid in Peroxisome Proliferator-Activated Receptor- (PPAR ) Generates a PPAR Phenotype

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors increase human sebum production

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptors: structures and function

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Medical significance of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

The anti-apoptotic role of PPARβ contributes to efficient skin wound healing

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Nuclear Hormone Receptors and Mouse Skin Homeostasis: Implication of PPARβ

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20998

21 January 2018

Identifiers

10.1002/JCP.20998

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36795404&oldid=1940511832"